IceCure Medical Ltd (ICCM) Stock

Healthcare · Medical Devices · Member of Other US Stocks

IceCure Medical Ltd (ICCM) closed at USD 1.04 on 2026-10-14, a change of -95.5 % over the past year, with a market capitalization of USD 4.82M.

IceCure Medical Ltd recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

IceCure Medical Ltd key figures

Previous close

USD 1.04 (2026-10-14)

1-year change

-95.5 %

Market cap

USD 4.82M

Enterprise value

USD -8.38M

P/E ratio (trailing)

-0.16

P/E ratio (forward)

-0.32

EPS (trailing)

-6.46

EPS (forward)

-3.31

PEG ratio

n/a

Price to book

0.30

Revenue growth

72.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.47

Employees

67

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About IceCure Medical Ltd

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for IceCure Medical Ltd and compare it with other stocks.